Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (OTCEM:ARDS) through any online brokerage.
There are no as such competitors for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc..
ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. has a consensus price target of $2.00.
The stock price for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (OTCEM: ARDS) is $0.0001 last updated October 2, 2026 at 2:58 PM EDT.
There are no upcoming dividends for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc..
ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc..
ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.